Obstetrics & Gynecology Ultrasound Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Portability (Cart/Trolley-Based, Portable/Handheld), By Product (2D Ultrasound, 3D/4D Ultrasound, Doppler Ultrasound), By End Use (Hospitals, Diagnostic Centers, Others), By Region and Competition, 2020-2030F

Market Overview

Global Obstetrics & Gynecology Ultrasound Devices Market was valued at USD 2.21 Billion in 2024 and is expected to reach USD 2.99 Billion by 2030 with a CAGR of 5.12% during the forecast period. The global obstetrics and gynecology ultrasound devices market is experiencing significant growth, driven by the rising prevalence of gynecological disorders, increasing pregnancy rates, and advancements in imaging technology. These devices are crucial for prenatal screening, fetal monitoring, and diagnosing various gynecological conditions. The market's expansion is further fueled by the growing preference for minimally invasive diagnostic procedures and the increasing awareness of maternal and fetal health.

Technological advancements in ultrasound imaging, such as 3D and 4D ultrasound and the integration of artificial intelligence (AI), have enhanced diagnostic accuracy and improved patient outcomes. AI-powered ultrasound systems help in automated image analysis, reducing the dependency on operator expertise. Additionally, portable and handheld ultrasound devices are gaining popularity due to their ease of use and accessibility, particularly in remote and resource-limited settings. These innovations are expected to drive further market adoption.

The demand for obstetrics and gynecology ultrasound devices is particularly high in developed regions such as North America and Europe, where advanced healthcare infrastructure and high healthcare expenditure facilitate rapid technology adoption. Meanwhile, emerging economies in Asia-Pacific and Latin America are witnessing a surge in market growth due to rising healthcare awareness, increasing disposable incomes, and government initiatives to improve maternal healthcare services. The expanding medical tourism in countries like India and Thailand further contributes to market growth. According to the Medical Tourism Index (MTI), Thailand secured the top position with a score of 79.53. The country boasts a highly developed medical tourism sector, offering world-class healthcare facilities at competitive costs.

 Key Market Drivers

Growing Prevalence of Gynecological Disorders

The global obstetrics and gynecology ultrasound devices market is experiencing significant growth, primarily driven by the increasing prevalence of gynecological disorders. According to a November 2024 article published in ScienceDirect, gynecological diseases ranked as the second most prevalent category among newly reported cases of non-communicable diseases.

Conditions such as polycystic ovary syndrome (PCOS), endometriosis, uterine fibroids, and ovarian cysts have become more common, leading to a rising demand for advanced diagnostic tools. Ultrasound devices play a critical role in early detection, monitoring, and management of these disorders, contributing to better patient outcomes. With healthcare providers emphasizing non-invasive and accurate diagnostic solutions, the adoption of obstetrics and gynecology ultrasound devices is gaining traction globally.

One of the major factors fueling this demand is the growing awareness of reproductive health and preventive diagnostics. Women are increasingly seeking medical attention for conditions affecting fertility and overall well-being, prompting healthcare systems to invest in high-quality imaging technologies. Ultrasound devices offer real-time imaging capabilities that aid in accurate diagnosis and treatment planning. Additionally, technological advancements, such as 3D and 4D imaging, have enhanced visualization and precision, further boosting the appeal of ultrasound in obstetric and gynecological applications.

The increasing incidence of high-risk pregnancies is another key driver of market growth. Rising maternal age, lifestyle changes, and the prevalence of conditions such as gestational diabetes and hypertension have led to an increased need for fetal monitoring. Obstetric ultrasound is a critical tool for ensuring fetal health and detecting complications at an early stage. The integration of artificial intelligence (AI) in ultrasound imaging has also improved diagnostic efficiency, reducing the risk of misinterpretation and enabling early interventions.

Government initiatives and healthcare investments are playing a vital role in expanding access to ultrasound services. Many countries are implementing policies to improve maternal and reproductive healthcare, particularly in developing regions where access to diagnostic tools has been historically limited. The rise in healthcare infrastructure and an increasing number of trained sonographers have further strengthened the market. Additionally, portable and handheld ultrasound devices are gaining popularity, allowing for better accessibility in remote and underserved areas.

Rising Maternal Health Awareness and Prenatal Care Adoption

The increasing awareness of maternal health and the growing adoption of prenatal care are significantly fueling the demand for obstetrics and gynecology ultrasound devices worldwide. Governments, healthcare organizations, and advocacy groups are actively promoting early and regular prenatal screenings, leading to a surge in the utilization of ultrasound technology. Expectant mothers and healthcare providers are becoming more conscious of the importance of fetal monitoring, early detection of complications, and ensuring optimal maternal well-being, contributing to the expansion of the ultrasound devices market in this segment. Adequate prenatal care is defined as prenatal care that begins early, before the 4th month of pregnancy and occurs on a regular basis, with the mother attending 80% or more of the expected number of prenatal care visits based on recommendations from the American College of Obstetricians and Gynecologists.

The technological advancements in ultrasound imaging have also played a crucial role in market growth. Modern ultrasound devices offer high-resolution imaging, 3D/4D capabilities, and real-time fetal monitoring, enhancing diagnostic accuracy for obstetricians and gynecologists. These innovations not only improve patient outcomes but also increase the preference for non-invasive diagnostic tools. Additionally, the integration of artificial intelligence (AI) in ultrasound imaging has streamlined workflows, reduced examination times, and enhanced image interpretation, making ultrasound a more effective and reliable option for prenatal care.

Government initiatives and healthcare policies supporting maternal health programs further contribute to market expansion. In several countries, public health initiatives emphasize routine ultrasound screenings as a part of standard prenatal care. Emerging economies, particularly in Asia-Pacific and South America, are witnessing increased investments in maternal and fetal healthcare infrastructure. This is driven by rising disposable incomes, improving healthcare access, and a higher number of hospital births, all of which support the demand for advanced ultrasound devices in obstetrics and gynecology. The growing incidence of pregnancy-related complications, such as gestational diabetes, preeclampsia, and congenital anomalies, underscores the necessity for frequent ultrasound monitoring. Healthcare providers rely on ultrasound to detect abnormalities at an early stage, enabling timely intervention and reducing maternal and neonatal morbidity. This has further strengthened the role of ultrasound technology in obstetrics, propelling the market growth.

The expansion of telemedicine and remote healthcare solutions has contributed to the increased adoption of portable and handheld ultrasound devices. These compact and cost-effective imaging tools are particularly beneficial in rural and underserved areas where access to traditional healthcare facilities is limited. The integration of mobile ultrasound solutions with digital health platforms enables remote consultations, improving prenatal care accessibility and outcomes. The global obstetrics and gynecology ultrasound devices market is experiencing robust growth due to rising maternal health awareness, increased prenatal care adoption, and technological advancements. Supportive government policies, improved healthcare infrastructure, and the demand for early detection of pregnancy complications are further driving the market forward. As maternal health continues to be a global priority, the adoption of innovative ultrasound solutions is expected to expand, ensuring better care for both mothers and newborns.

Download Free Sample Report

Key Market Challenges

High Cost of Advanced Ultrasound Systems

One of the primary challenges in the OB/GYN ultrasound devices market is the high cost associated with advanced imaging systems. Cutting-edge ultrasound machines with 3D/4D and Doppler capabilities come at a premium, making them less accessible for smaller healthcare facilities, particularly in developing regions. This cost barrier not only limits market penetration but also forces hospitals and clinics to rely on older, less efficient equipment, reducing the adoption rate of newer technologies.

Reimbursement and Insurance Limitations

Reimbursement policies for ultrasound procedures vary significantly across different healthcare systems. In some countries, inadequate insurance coverage for OB/GYN ultrasound scans leads to out-of-pocket expenses for patients, reducing demand for these procedures. Moreover, the complex reimbursement landscape can discourage healthcare providers from investing in advanced ultrasound equipment, thereby limiting market expansion.

Key Market Trends

Technological Advancements Enhancing Diagnostic Capabilities

One of the most prominent trends in the market is the continuous advancement in ultrasound technology. The transition from 2D ultrasound to 3D and 4D imaging, as well as the integration of artificial intelligence (AI) and machine learning, has significantly improved diagnostic accuracy. AI-powered ultrasound systems are enabling automated fetal anomaly detection, reducing examination times and enhancing clinical workflow efficiency. Additionally, the development of Doppler ultrasound and elastography techniques is further expanding the capabilities of ultrasound devices, allowing for better assessment of blood flow and tissue elasticity in gynecological conditions. In April 2022, a study published in NEJM Evidence presented a groundbreaking opportunity to expand access to obstetric ultrasound. Researchers from the University of North Carolina’s (UNC) Institute for Global Health & Infectious Diseases (IGHID), UNC School of Medicine, and the UNC Gillings School of Global Public Health (GSPH) have developed an advanced deep-learning artificial intelligence (AI) model. This innovative technology enables accurate estimation of gestational age using a point-of-care ultrasound (POCUS) device, enhancing accessibility and efficiency in prenatal care.

Rising Demand for Portable and Handheld Ultrasound Devices

The market is experiencing a growing demand for portable and handheld ultrasound devices, particularly in point-of-care settings and remote healthcare facilities. These compact and wireless ultrasound systems are transforming prenatal care by allowing real-time imaging in ambulatory settings and home-based care, especially in low-resource regions. The increasing use of telemedicine and remote diagnostics has further fueled the adoption of handheld ultrasound devices, enabling healthcare professionals to conduct virtual consultations and improve access to maternal healthcare in underserved areas.

Segmental Insights

Product Insights

Based on product, 3D/4D ultrasound has emerged as the fastest-growing segment in the Global Obstetrics & Gynecology Ultrasound Devices Market in 2024. can be attributed to several key factors, including technological advancements, rising patient preference for enhanced imaging, and increasing adoption by healthcare providers. Unlike traditional 2D ultrasound, which provides flat, grayscale images, 3D ultrasound generates more detailed, three-dimensional representations of the fetus, while 4D ultrasound adds the dimension of real-time motion, allowing parents and physicians to observe fetal movements and facial expressions with greater clarity. This technological leap has significantly improved diagnostic accuracy in detecting congenital anomalies and structural abnormalities, leading to a surge in demand from both clinicians and expectant mothers. Another major driver of the 3D/4D ultrasound segment is the growing emphasis on early and precise prenatal diagnostics. With the increasing awareness of fetal health and the rising incidence of pregnancy-related complications, healthcare providers are prioritizing advanced imaging solutions that enable early detection of conditions such as cleft lip, neural tube defects, and cardiac anomalies. This has led to wider adoption of 3D/4D ultrasound in obstetrics and gynecology clinics, as these technologies offer enhanced visualization and facilitate better clinical decision-making. Additionally, the integration of artificial intelligence (AI) and automation in ultrasound imaging has made these devices more efficient, reducing scan time while improving diagnostic reliability. Consumer preference and emotional appeal play a significant role in the market expansion of 3D/4D ultrasound. Many expecting parents opt for 3D/4D scans due to their ability to provide lifelike images and videos of the fetus, enhancing the bonding experience during pregnancy. This demand is further fueled by social media trends, where parents share detailed ultrasound images, encouraging others to seek similar experiences. With an increasing number of private clinics offering elective 3D/4D ultrasound sessions, the segment has witnessed strong commercial growth beyond traditional medical applications.  

Download Free Sample Report

Regional Insights

Based on Region, North America emerged as the dominating region in the Global Obstetrics & Gynecology Ultrasound Devices Market in 2024, due to several key factors, including advanced healthcare infrastructure, high adoption rates of cutting-edge medical technologies, and increasing demand for prenatal and gynecological care. The region, particularly the United States and Canada, has a well-established network of hospitals, specialty clinics, and diagnostic centers that frequently utilize ultrasound imaging for obstetric and gynecological examinations. The presence of leading ultrasound device manufacturers, along with strong government support for maternal and reproductive health, further strengthened North America's position in the market. Another critical driver is the growing prevalence of high-risk pregnancies and gynecological disorders, which has led to an increased demand for advanced diagnostic tools. The region has witnessed a steady rise in maternal age, a factor associated with pregnancy complications, necessitating frequent ultrasound monitoring. Additionally, increasing awareness about the benefits of early disease detection, such as in ovarian or uterine conditions, has spurred the adoption of high-resolution ultrasound devices in gynecological applications. The availability of technologically advanced ultrasound systems, including 3D and 4D imaging, Doppler ultrasound, and AI-integrated ultrasound solutions, has further propelled market growth in North America. Favorable reimbursement policies and healthcare expenditure in the region have encouraged the adoption of premium ultrasound devices. In the United States, government and private insurance providers offer reimbursement for various obstetric and gynecological ultrasound procedures, making these diagnostics more accessible to patients. The presence of key players such as GE HealthCare, Philips, and Siemens Healthineers, which continuously invest in innovation and product development, has also contributed to the region's leadership in the market.

Recent Development

• In January 2025, Korea-based Samsung Medison introduced its latest AI-powered obstetrics and gynecology (OB/GYN) ultrasound system in the U.S. The company unveiled the Samsung Z20 at the Society for Maternal-Fetal Medicine (SMFM) 2025. According to the company, the system is equipped with Live ViewAssist, a real-time deep learning tool designed to enhance diagnostic precision and streamline advanced obstetrical examinations. Additional features include automatic identification and labeling, real-time quality assessment, and automated measurements, reinforcing its capability to improve clinical efficiency and accuracy.
• In April 2024, GE HealthCare launched the Voluson Signature 20 and 18 ultrasound systems, integrating artificial intelligence (AI) and voice command capabilities to enhance diagnostics in women's health. Key features include automated fetal anatomy measurements, pelvic floor imaging, and fibroid mapping. The "Hey Voluson" voice command streamlines workflows by reducing examination time and keystrokes, improving overall efficiency.
• In February 2023, Samsung introduced the HERA W10 Elite, a cutting-edge AI-powered ultrasound system designed for obstetrics and gynecology. Equipped with HeartAssist for automated fetal heart measurements and Advanced MV-Flow for enhanced blood flow visualization, the system improves diagnostic precision. Additionally, it features a high-resolution OLED display, ensuring superior imaging quality.
• In October 2020, Samsung Medison introduced its new Intelligent Assist solutions, enhancing its capabilities in diagnostic solutions. The company announced the launch of these solutions during the virtual ISUOG (International Society of Ultrasound in Obstetrics & Gynecology) World Congress 2020.

Key Market Players

• GE Healthcare Technologies Inc.
• Siemens Healthcare Private Limited
• Koninklijke Philips N.V.
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• FUJIFILM Corporation
• SamsungHealthcare.com
• Esaote SPA
• CANON MEDICAL SYSTEMS CORPORATION
• CHISON Medical Technologies Co., Ltd.

Report Scope

In this report, the Global Obstetrics & Gynecology Ultrasound Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Obstetrics & Gynecology Ultrasound Devices Market, By Portability:

o   Cart/Trolley

o   Portable/Handheld

• Obstetrics & Gynecology Ultrasound Devices Market, By Product:

o   2D Ultrasound

o   3D/4D Ultrasound

o   Doppler Ultrasound

• Obstetrics & Gynecology Ultrasound Devices Market, By End Use:

o   Hospitals

o   Diagnostic Centers

o   Others

• Obstetrics & Gynecology Ultrasound Devices Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Obstetrics & Gynecology Ultrasound Devices Market.

Available Customizations:

Global Obstetrics & Gynecology Ultrasound Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Obstetrics & Gynecology Ultrasound Devices Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com